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Editorial
The “Code of Ethics of the Italian 
National Institute of Health”
The ITalIan naTIonal InsTITuTe 
of healTh, The eThICs CommITTee 
and The Code
On 13th January 2015 the Ethics Committee of the Is-
tituto Superiore di Sanità (ISS, Italian National Institute 
of Health) adopted the “Code of Ethics of the Italian Na-
tional Institute of Health” [1], which was implemented by 
means of an ad hoc Order [2].
The ethical principles, values and criteria affirmed in 
the Code reflect the multitude and broad range of activi-
ties and functions performed by the Institute. As stated 
in its statute, the Institute “pursues the protection of 
public health, especially through the exercise of research, 
control, consultancy, regulatory and training activities” 
[3]. The Institute’s research studies range from basic re-
search to clinical and diagnostic applications in a transla-
tional perspective, while its institutional responsibilities 
cover the whole range of public health interventions.
It follows from this that the activities of the Institute’s 
Ethics Committee also range over the numerous fields of 
research in which the ISS is engaged. In accordance with 
article 12 (paragraph 10) of Law 189 of 8th November 
2012 [4] and the Decree of 8th February 2013 [5], its 
key function is the evaluation and authorization of clini-
cal trials, but it is also involved in the whole range of ac-
tivities pursued by and through the Institute, a peculiar-
ity that is reflected in the fact that the Ethics Committee 
of the ISS is designated as being of “national importance” 
[6] and is not subject to local planning procedures for 
Ethics Committee laid down in current regulations [5].
The document is defined as a “Code” in the broadest 
sense of the word’s meaning. According to The new dic-
tionary of medical ethics codes are texts that “serve prin-
cipally to lay down the rights and duties which should 
underpin professional practice” [7]. Codes may come in 
different forms and be variously grouped, but the “main 
difference in classification is not in the content but in 
who the reader of the code is” [8]. The “Code of Ethics 
of the Italian National Institute of Health” [1] (hereafter 
referred to as the “Code”) can be included among those 
that Harris defines as a “code of conduct” and which he 
describes “as a document prepared for the benefit and 
regulation of the group” [9].
The ConTenTs of The Code
The Code comprises five chapters preceded by a brief 
foreword explaining its origins and structure. The five 
chapters concern: integrity in research, conflicts of in-
terest, trials with human subjects, public health, experi-
ments involving animals.
In the first chapter the Committee decided to adopt 
the “Executive summary” of the “European Code of con-
duct for research integrity” [10] drawn up by the Europe-
an Science Foundation (ESF) and the federation of All 
European Academies (ALLEA), which brings together 
53 national academies from 43 states. The “European 
Code of conduct for research integrity” is considered 
one of the most authoritative codes on the subject cur-
rently circulating in the European Union and has been 
adopted by several institutions. The principle of integrity 
in research  applies in particular to: honesty in presenting 
goals and intentions; reliability of research; fairness in 
communication; objectivity; independent and impartial 
communication with other researchers and with the pub-
lic; duty of care for humans, animals, the environment; 
fairness in providing references and giving credit for the 
work of others; responsibility for future generations in 
the supervision of young scientists and scholars.
Unlike the first chapter, the ensuing chapters do not 
adhere strictly to documents already adopted by other in-
stitutions. They nonetheless refer to values and principles 
that are widely shared and affirmed in the major ethical 
codes concerning biomedicine in general and research 
with human subjects, including: the World Medical As-
sociation’s “Declaration of Helsinki” [11], the “Conven-
tion for the Protection of Human Rights and Dignity of 
the Human Being with regard to the Application of Biol-
ogy and Medicine: Convention on Human Rights and 
Biomedicine” published by the Council of Europe [12], 
and the “International Ethical Guidelines for Biomedical 
Research Involving Human Subjects” published by the 
Council for International Organizations of Medical Sci-
ences [13].
The second chapter introduces general criteria for the 
management of possible conflicts of interest that might 
compromise the independence of researchers or the im-
partiality of their professional activities. As the Institute 
is part of a vast network of national and international 
contacts, it is to be expected that situations may arise in 
which conflicts of interest, whether of an economic or 
non-economic nature, are a possibility. The Code pro-
poses a “Declaration of Interests” (DoI) form on which 
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researchers and all the Institute’s personnel detail the 
circumstances in which such conflicts may emerge. The 
implementation of practical rules and supervision are 
not the responsibility of the Ethics Committee but of the 
Central Administration.
The third chapter addresses issues concerning trials 
with human subjects. Although the Institute is not a 
centre for the direct treatment of patients, it both co-
ordinates and participates in multicentre trials. In ethi-
cal terms the issue is of major importance: clinical trials 
call for very careful evaluation, primarily on account of 
the possible risks they may involve and their possible di-
rect effects on the health of individuals. This is why the 
evaluations expressed by the Ethics Committee on other 
types of research are in the form of opinions, whereas 
those regarding clinical trials are either a legally valid au-
thorisation or a legally binding ban. The Code provides 
guidance regarding: the value and validity of research 
projects, the fair selection of subjects, risk-benefit ratios, 
independent review, informed consent, respect for po-
tential and enrolled subjects. While the Code does not 
aim to offer either an interpretation of current legisla-
tion or guidelines for its interpretation, the third chap-
ter mentions both the difficulties involved when patients 
are unable to express consent and the Italian regulations 
concerning legal representation when their participation 
in clinical trials is envisaged.
The fourth chapter moves to the broader sphere of 
public health research and interventions, in other words 
from a primarily individual dimension to one embracing 
the public at large. The competition – at times a clash – 
between the two dimensions gives rise to one of the key 
problems for public health ethics. The maximisation of 
the community good must not be allowed to compro-
mise the good of individual subjects. The Code therefore 
recalls the ethical principle that the collective good is 
achieved by protecting and promoting the good of each 
and every individual.
The final chapter introduces the basic ethical criteria 
for trials involving animals. Experiments with animal 
models must be scientifically valid, methodologically ap-
propriate, statistically reasonable, and original. While the 
Code is not a practical guide to the application of regula-
tions, the text takes into account the situation in Italy 
following the entry into force of the Legislative Decree 
of 4th March 2014 [14] which transposed the EU Direc-
tive (2010/63/EU) on the protection of animals used for 
scientific purposes [15].
The Code thus affirms the basic ethical criteria that 
should underpin the Institute’s numerous activities in 
the broad fields of biomedicine and public health, with 
particular emphasis on research. These criteria reiterate 
principles regarding such questions as basic research, tri-
als with human subjects and public health that are wide-
ly shared, albeit generally treated separately in texts on 
more specific issues.
Although the Institute has always pursued principles 
and values that are unanimously held to be inalienable, the 
Code is the first such document to be adopted.
For the Institute’s numerous activities the Code is a 
fixed point of reference, but nonetheless not a definitive 
one: it will be updated as and when circumstances require.
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